// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Shipping-related particulate matter air pollution – source-specific effects on bronchial epithelial cells

Natasha Easton - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Why are specific inhalation challenges (SIC) negative in workers with suspected occupational asthma?

Annasiwatte Niranjala - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Prenatal, early-life and childhood exposure to air pollution and lung function in the UK Avon Longitudinal Study of Parents and Children (ALSPAC) cohort

Anna Hansell - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The potential for air purification to reduce children’s overall pollution exposure

Norrice Liu - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

LSC - 2019 - Novel cellular effects of ultrafine particulate matter from an underground railway station uncovered through RNAseq

Matthew Loxham - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma

David Lo - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

By how much can exhaled nitric oxide vary over three months in children with stable asthma?

Stephen Turner - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Routine clinical use of Electronic Monitoring Devices (EMD) to measure inhaler adherence in children with Difficult Asthma (DA)

Susan Frost - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The suitability of exhaled breath compounds to identify children with exercise induced bronchoconstriction is modulated by the use of inhaled corticosteroids

Mattienne van der Kamp - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Meta-analysis of inhaled corticosteroids response in children with asthma

Natalia Hernandez-Pacheco - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A three months period of electronic monitoring is sufficient to assess adherence and improve asthma control

Anja Jochmann - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Assessment of adrenal function using low and standard dose synacthen tests in a cohort of paediatric asthma patients

Louise Selby - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Tetracosactide

Intra-device repeatability of the NIOX-MINO handheld fractional exhaled nitric oxide monitor

Spencer Williams - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nitric oxide

Mepolizumab eligibility in children with severe asthma – do we need paediatric specific criteria?

Benjamin Davies - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Defining Near Fatal asthma – an international eDelphi study

Ann Mcmurray - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Methadone hydrochloride

Addressing attitudes and awareness of asthma amongst peers through theatre

Kate Harris - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Transition to independent self-management among children with asthma

Siti Nurkamilla Ramdzan - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Experiences of participating in a new integrated programme of asthma care: patients and parents’ perspectives

Lucy Gait - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Patient-reported outcomes in preschool children with wheeze

Katelyn Aitchison - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma

Chris Grime - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sleep apnoea

N/A

Copyright © 2026. QuantiNova All rights reserved